Letter by Lensen et al Regarding Article, "Anti-Tumor Necrosis Factor- Therapy Reduces Aortic Inflammation and Stiffness in Patients With Rheumatoid Arthritis"

被引：1
|
作者：
Lensen, Karel-Jan D. F. [1 ]
van Sijl, Alper M. [1 ]
Smulders, Yvo M. [1 ]
机构：
[1] Vrije Univ Amsterdam Med Ctr, Dept Internal Med, Inst Cardiovasc Res, Amsterdam, Netherlands
来源：
CIRCULATION | 2013年 / 128卷 / 01期
关键词：
F-18-FDG PET; ATHEROSCLEROSIS;
D O I：
10.1161/CIRCULATIONAHA.112.000549
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：E10 / E10
页数：1
相关论文
共 50 条
  • [21] Anti-tumor necrosis factor-α therapy is associated with less frequent mood and anxiety disorders in patients with rheumatoid arthritis
    Uguz, Faruk
    Akman, Cemal
    Kucuksarac, Seher
    Tufekci, Osman
    PSYCHIATRY AND CLINICAL NEUROSCIENCES, 2009, 63 (01) : 50 - 55
  • [22] Anti-tumor necrosis factor-α therapy and changes of flow-mediated vasodilatation in psoriatic and rheumatoid arthritis patients
    Gianluigi Mazzoccoli
    Incoronata Notarsanto
    Gennaro Davide de Pinto
    Mariangela Pia Dagostino
    Angelo De Cata
    Giuseppe D’Alessandro
    Roberto Tarquini
    Gianluigi Vendemiale
    Internal and Emergency Medicine, 2010, 5 : 495 - 500
  • [23] Should anti-tumor necrosis factor-α be the first therapy for rheumatoid vasculitis?
    Garcia-Porrua, C
    Gonzalez-Gay, MA
    JOURNAL OF RHEUMATOLOGY, 2006, 33 (02) : 433 - 433
  • [24] Anti-tumor necrosis factor-alpha therapy of rheumatoid arthritis
    Feldmann, M
    Elliott, MJ
    Woody, JN
    Maini, RN
    ADVANCES IN IMMUNOLOGY, VOL 64, 1997, 64 : 283 - 350
  • [25] Effects of anti-tumor necrosis factor therapy on lipid profile in patients with rheumatoid arthritis
    Soubrier, Martin
    Jouanel, Pierre
    Mathieu, Sylvain
    Poujol, David
    Claus, Delphine
    Dubost, Jean Jacques
    Ristori, Jean Michel
    JOINT BONE SPINE, 2008, 75 (01) : 22 - 24
  • [26] Septic arthritis caused by Actinobacillus ureae in a patient with rheumatoid arthritis receiving anti-tumor necrosis factor-α therapy
    Kaur, PP
    Derk, CT
    Chatterji, M
    Dehoratius, RJ
    JOURNAL OF RHEUMATOLOGY, 2004, 31 (08) : 1663 - 1665
  • [27] Anti-tumor necrosis factor-α agents for rheumatoid arthritis:: Assessing longterm safety
    Hyrich, KL
    Silman, AJ
    JOURNAL OF RHEUMATOLOGY, 2006, 33 (05) : 831 - 833
  • [28] Risk of Significant Infection in Rheumatoid Arthritis Patients Switching Anti-Tumor Necrosis Factor-α Drugs
    Bao-Anh Nguyen-Khoa
    Goehring, Earl L., Jr.
    Alexander, Kimberly A.
    Dong, Wei
    Napalkov, Pavel
    Jones, Judith K.
    SEMINARS IN ARTHRITIS AND RHEUMATISM, 2012, 42 (02) : 119 - 126
  • [29] Staphylococcus aureus in patients with rheumatoid arthritis under conventional and anti-tumor necrosis factor-α treatment
    Bassetti, S
    Wasmer, S
    Hasler, P
    Vogt, T
    Nogarth, D
    Frei, R
    Widmer, AF
    JOURNAL OF RHEUMATOLOGY, 2005, 32 (11) : 2125 - 2129
  • [30] Rheumatoid arthritis is associated with increased aortic pulse-wave velocity, which is reduced by anti-tumor necrosis factor-α therapy
    Maki-Petaja, Kaisa M.
    Hall, Frances C.
    Booth, Anthony D.
    Wallace, Sharon M. L.
    Yasmin
    Bearcroft, Philip W. P.
    Harish, Srinivasan
    Furlong, Anita
    McEniery, Carmel M.
    Brown, John
    Wilkinson, Ian B.
    CIRCULATION, 2006, 114 (11) : 1185 - 1192
12345